Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:53 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 188 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Fractional Clear all

Conditions: Acne, Wrinkle
Interventions: BTL-585F; Device
Lead sponsor: BTL Industries Ltd.; Industry
Eligibility: 21 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Davie, Florida • New York, New York

Conditions: Peripheral Arterial Disease, Fractional Flow Reserve, Hemodynamics
Interventions: Translesional Hemodynamic Measurement; Device
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: HPV Infection, HPV Vaccine
Interventions: HPV vaccine; Biological
Lead sponsor: University of Washington; Other
Eligibility: 27 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Keratinocyte Carcinoma, Basal Cell Carcinomas, Squamous Cell Carcinoma, Skin Cancer
Interventions: Tirbanibulin ointment 1%, non-ablative fractional laser; Drug · Device
Lead sponsor: Bruce Robinson, MD; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: Stable Angina, Unstable Angina, NSTEMI
Interventions: Collecting invasive FFR measurements.; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Asthma
Interventions: NIOX MINO®; Device
Lead sponsor: Aerocrine AB; Industry
Eligibility: 7 Years to 65 Years
Enrollment: 235 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 13
States / cities: Byron, Minnesota • Chatfield, Minnesota • Pine Island, Minnesota + 7 more

Conditions: Non-obstructive Coronary Disease, Acute or Chronic Coronary Artery Disease
Interventions: Patients with intermediate coronary artery stenosis with clinically indicated FFR assessment., Microvascular assessment; Procedure
Lead sponsor: AngioInsight; Industry
Eligibility: 18 Years and older
Enrollment: 620 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 10
States / cities: Palo Alto, California • Washington D.C., District of Columbia • Minneapolis, Minnesota + 4 more

Conditions: Skin Laxity, Lipodystrophy
Interventions: Rotational fractional resection (1.5mm Diameter Device); Device
Lead sponsor: Recros Medica, Inc.; Industry
Eligibility: 30 Years and older
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Photoaging, Wrinkle, Skin Laxity
Interventions: Hybrid Fractional Laser, Facial Cleanser, Facial Moisturizer, Sunscreen; Procedure · Other
Lead sponsor: Revision Skincare; Industry
Eligibility: 35 Years to 65 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Atlanta, Georgia • Dallas, Texas

Conditions: Acquired Absence of Lower Limb, Scar Condition and Fibrosis of the Skin
Interventions: Fractional CO2 Laser Ablative Resurfacing; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Miami, Florida • Tampa, Florida

Conditions: Polio
Interventions: dmLT, fIPV; Biological
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years to 45 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Coronary Artery Disease
Interventions: PET-MPI Protocol, CT-MPI, Coronary CT angiography (CCTA) for CT-FFR calculation, Regadenoson; Diagnostic Test · Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Acute Myocardial Infarction, STEMI, Coronary Artery Disease, Atherosclerotic Plaque Disruption With Thrombosis of Artery
Interventions: Coronary Angiography; Procedure
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Port Wine Stains
Interventions: Matrix RF, Matrix RF followed by Pulse Dye Laser, Pulse Dye Laser followed by Matrix RF; Device
Lead sponsor: Syneron Medical; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Acne Scars - Mixed Atrophic and Hypertrophic, Hyperpigmentation, Laser-Induced Hyperpigmentation
Interventions: Sciton Halo; Device
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Elmsford, New York

Conditions: Burn Wound
Interventions: Cellutome Device, Standard of Care; Device · Other
Lead sponsor: Lehigh Valley Hospital; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Allentown, Pennsylvania

Conditions: PD Effects of GS-0976 (NDI-010976) on Fractional DNL
Interventions: GS-0976, Placebo, 1-13C acetate, Fructose solution; Drug · Other
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Wrinkle
Interventions: Tixel 2; Device
Lead sponsor: Physicians Laser and Dermatology Institute; Other
Eligibility: 35 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Wrinkles, Acne Scars
Interventions: Alma Lasers Accent RF Pixel handpiece; Device
Lead sponsor: Alma Lasers Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 3
States / cities: Glenview, Illinois • Las Vegas, Nevada • Bryn Mawr, Pennsylvania

Conditions: Scar
Interventions: Fraxel Laser, CO2 Laser; Device
Lead sponsor: Marta Hemmingson-Van Beek; Other
Eligibility: 18 Years to 120 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Coronary Artery Disease
Interventions: ElucidVivo; Device
Lead sponsor: Elucid Bioimaging Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 439 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 8
States / cities: Beverly Hills, California • Atlanta, Georgia • Fort Wayne, Indiana + 5 more

Conditions: Coronary Artery Disease, Stable Angina, Unstable Angina, Non-ST-Elevation Myocardial Infarction
Interventions: MedHub AutocathFFR; Device
Lead sponsor: Medhub Ltd.; Industry
Eligibility: 23 Years and older
Enrollment: 277 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Atlanta, Georgia • Gainesville, Georgia + 1 more

Conditions: Genitourinary System; Disorder, Female, Burning Vagina, Dyspareunia, Irritation; Vagina, Menopause Related Conditions, Urinary Incontinence, Urinary Bladder, Overactive, Urinary Tract Infections, Stress Urinary Incontinence
Interventions: fCO2 Laser Therapy Group; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 90 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Coronary Artery Stenoses, Aortic Stenosis
Interventions: Volcano iFR/FFR Verrata Plus coronary pressure/flow wire; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 20 Years to 110 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Fractional Radiofrequency for Treatment of Acne Scars and Wrinkles

TRanslesIonal Assessment of Gradients During Endovascular Therapy

Intradermal, Fractional Dose of HPV Vaccines:

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

Evaluation of a Novel Non-Invasive Automated Fractional Flow Reserve Software System in Patients With Coronary Artery Disease

Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms

Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study

The PREFORM Study: Rotational Fractional Resection for Submental Contouring

Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional Laser for Facial Rejuvenation

LASER Pilot Project

Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant

The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI

Multi-modality Imaging in Acute Myocardial Infarction

Port Wine Stains Treatment Matrix RF Study

Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color

Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique

Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult Subjects

A Prospective, Single Center, Single-Arm Clinical Study of 20 Participants to Reduce the Appearance of the Peri-orbital Wrinkles. Participants Will Receive up to Four Treatments With Tixel Every 4 Weeks. Follow-up Will Occur 1 Month and 3 Months Following Last Treatment.

Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles

Comparison of Lasers in the Treatment of Scars

ELUCIDATE FFRct Study

Validation of the MedHub AutocathFFR Software Device for Non-Invasive Fractional Flow Reserve (FFR)

Laser Therapy for Treatment of Urogenital Symptoms in Women

A Prospective Study of Fractional Flow Reserve Assessment of Intermediate Coronary Stenoses in Severe Aortic Stenosis